{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:53:11Z","timestamp":1791859991120,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>The present study aimed to investigate the effects of nano-curcumin supplementation on adipokines levels and clinical signs in obese and overweight patients with migraine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Forty-four patients with episodic migraine participated in this clinical trial and were divided into two groups nano-curcumin (80\u00a0mg\/day) and the control group over 2-month period. At the baseline and the end of the research, the serum levels of MCP-1, Resistin, and Visfatin were measured using the ELISA method. In addition, the headache attack frequencies, severity, and duration of pain were recorded. The results of the present study showed that nano-curcumin can significantly reduce MCP-1 serum levels in the nano-curcumin supplemented group (P\u2009=\u20090.015, size effect\u2009=\u200913.4%). In the case of resistin and visfatin, nano-curcumin supplementation exerted no statistically significant changes in serum levels (P\u2009&gt;\u20090.05). Nano-curcumin also significantly reduced the attack frequencies, severity, and duration of headaches (P\u2009&lt;\u20090.05). These findings indicate that targeting curcumin can be a promising approach to migraine management. However, further comprehensive human trials are needed to confirm these findings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial Registration<\/jats:title>\n                <jats:p>This study was registered in the Iranian Registry of Clinical Trials (IRCT) with ID number: IRCT20160626028637N2 on the date 2020-07-10.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13104-022-06074-4","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T11:04:25Z","timestamp":1653303865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The effects of nano-curcumin supplementation on adipokines levels in obese and overweight patients with migraine: a double blind clinical trial study"],"prefix":"10.1186","volume":"15","author":[{"given":"Mohsen","family":"Sedighiyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Abdolahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Vahabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Sohrabi Athar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shima","family":"Hadavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Narimani Zamanabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir-Saeed","family":"Yekaninejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Djalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"issue":"1","key":"6074_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"M Arnold","year":"2018","unstructured":"Arnold M. Headache classification committee of the international headache society (IHS) the international classification of headache disorders. Cephalalgia. 2018;38(1):1\u2013211.","journal-title":"Cephalalgia"},{"issue":"6","key":"6074_CR2","doi-asserted-by":"publisher","first-page":"e00950","DOI":"10.1002\/brb3.950","volume":"8","author":"WZ Yeh","year":"2018","unstructured":"Yeh WZ, Blizzard L, Taylor BV. What is the actual prevalence of migraine? Brain Behav. 2018;8(6):e00950.","journal-title":"Brain Behav"},{"key":"6074_CR3","unstructured":"Disorders A-PPGoPH. Headache disorders\u2014not respected, not resourced. 2010."},{"issue":"21","key":"6074_CR4","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1212\/01.wnl.0000262045.11646.b1","volume":"68","author":"ME Bigal","year":"2007","unstructured":"Bigal ME, Lipton RB, Holland PR, Goadsby PJ. Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology. 2007;68(21):1851\u201361.","journal-title":"Neurology"},{"issue":"2","key":"6074_CR5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1526-4610.2008.01232.x","volume":"49","author":"AD Hershey","year":"2009","unstructured":"Hershey AD, Powers SW, Nelson TD, Kabbouche MA, Winner P, Yonker M, et al. Obesity in the pediatric headache population: a multicenter study. Headache J of Head Face Pain. 2009;49(2):170\u20137.","journal-title":"Headache J of Head Face Pain"},{"issue":"11","key":"6074_CR6","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1177\/0333102416665871","volume":"37","author":"E Rubino","year":"2017","unstructured":"Rubino E, Vacca A, Govone F, Gai A, Boschi S, Zucca M, et al. Investigating the role of adipokines in chronic migraine. Cephalalgia. 2017;37(11):1067\u201373.","journal-title":"Cephalalgia"},{"issue":"14","key":"6074_CR7","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1212\/WNL.0000000000001443","volume":"84","author":"NC Chai","year":"2015","unstructured":"Chai NC, Gelaye B, Tietjen GE, Dash PD, Gower BA, White LW, et al. Ictal adipokines are associated with pain severity and treatment response in episodic migraine. Neurology. 2015;84(14):1409\u201318.","journal-title":"Neurology"},{"issue":"1\u20132","key":"6074_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jneuroim.2005.10.005","volume":"171","author":"I Fidan","year":"2006","unstructured":"Fidan I, Y\u00fcksel S, \u00ddmir T, \u0130rke\u00e7 C, Aksakal FN. The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol. 2006;171(1\u20132):184\u20138.","journal-title":"J Neuroimmunol"},{"key":"6074_CR9","first-page":"24","volume":"23","author":"C Li","year":"2017","unstructured":"Li C, Zhu Q, He Q, Wang J, Wang F, Zhang H. Plasma levels of cyclooxygenase-2 (COX-2) and visfatin during different stages and different subtypes of migraine headaches. Med Sci Monitr Int Med J Exp Clin Res. 2017;23:24.","journal-title":"Med Sci Monitr Int Med J Exp Clin Res"},{"key":"6074_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.nbd.2017.01.005","volume":"101","author":"M Martins-Oliveira","year":"2017","unstructured":"Martins-Oliveira M, Akerman S, Holland PR, Hoffmann JR, Tavares I, Goadsby PJ. Neuroendocrine signaling modulates specific neural networks relevant to migraine. Neurobiol Dis. 2017;101:16\u201326.","journal-title":"Neurobiol Dis"},{"issue":"12","key":"6074_CR11","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1093\/rheumatology\/ket294","volume":"52","author":"H Fragoso-Loyo","year":"2013","unstructured":"Fragoso-Loyo H, Atisha-Fregoso Y, Llorente L, S\u00e1nchez-Guerrero J. Inflammatory profile in cerebrospinal fluid of patients with headache as a manifestation of neuropsychiatric systemic lupus erythematosus. Rheumatology. 2013;52(12):2218\u201322.","journal-title":"Rheumatology"},{"issue":"9","key":"6074_CR12","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.4049\/jimmunol.174.9.5789","volume":"174","author":"M Bokarewa","year":"2005","unstructured":"Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005;174(9):5789\u201395.","journal-title":"J Immunol"},{"issue":"1","key":"6074_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2008.11.024","volume":"205","author":"R Adya","year":"2009","unstructured":"Adya R, Tan BK, Chen J, Randeva HS. Pre-B cell colony enhancing factor (PBEF)\/visfatin induces secretion of MCP-1 in human endothelial cells: role in visfatin-induced angiogenesis. Atherosclerosis. 2009;205(1):113\u20139.","journal-title":"Atherosclerosis"},{"issue":"3","key":"6074_CR14","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1468-2982.2008.01727.x","volume":"29","author":"S B\u00f8","year":"2009","unstructured":"B\u00f8 S, Davidsen E, Gulbrandsen P, Dietrichs E, Bovim G, Stovner L, et al. Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia. 2009;29(3):365\u201372.","journal-title":"Cephalalgia"},{"issue":"12","key":"6074_CR15","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1002\/jcb.26121","volume":"118","author":"J Hajavi","year":"2017","unstructured":"Hajavi J, Momtazi AA, Johnston TP, Banach M, Majeed M, Sahebkar A. Curcumin: a naturally occurring modulator of adipokines in diabetes. J Cell Biochem. 2017;118(12):4170\u201382.","journal-title":"J Cell Biochem"},{"issue":"1","key":"6074_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep09862","volume":"5","author":"N Ahsan","year":"2015","unstructured":"Ahsan N, Mishra S, Jain MK, Surolia A, Gupta S. Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of wild type and mutant \u03b1-Synuclein. Sci Rep. 2015;5(1):1\u201316.","journal-title":"Sci Rep"},{"issue":"2","key":"6074_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1358\/dof.2010.035.02.1426640","volume":"35","author":"A Shehzad","year":"2010","unstructured":"Shehzad A, Lee Y. Curcumin: multiple molecular targets mediate multiple pharmacological actions: a review. Drugs Fut. 2010;35(2):113.","journal-title":"Drugs Fut"},{"issue":"1","key":"6074_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00280-011-1673-1","volume":"69","author":"M Kanai","year":"2012","unstructured":"Kanai M, Imaizumi A, Otsuka Y, Sasaki H, Hashiguchi M, Tsujiko K, et al. Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. Cancer Chemother Pharmacol. 2012;69(1):65\u201370.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"6074_CR19","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1210\/en.2011-1413","volume":"153","author":"S-R Kim","year":"2012","unstructured":"Kim S-R, Park H-J, Bae Y-H, Ahn S-C, Wee H-J, Yun I, et al. Curcumin down-regulates visfatin expression and inhibits breast cancer cell invasion. Endocrinology. 2012;153(2):554\u201363.","journal-title":"Endocrinology"},{"key":"6074_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cytogfr.2016.10.001","volume":"33","author":"MS Karimian","year":"2017","unstructured":"Karimian MS, Pirro M, Majeed M, Sahebkar A. Curcumin as a natural regulator of monocyte chemoattractant protein-1. Cytokine Growth Factor Rev. 2017;33:55\u201363.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"12","key":"6074_CR21","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1002\/ptr.3463","volume":"25","author":"MM Pirvulescu","year":"2011","unstructured":"Pirvulescu MM, Gan AM, Stan D, Simion V, Calin M, Butoi E, et al. Curcumin and a Morus alba extract reduce pro-Inflammatory effects of resistin in human endothelial cells. Phytother Res. 2011;25(12):1737\u201342.","journal-title":"Phytother Res"},{"issue":"3","key":"6074_CR22","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1526-4610.2006.00382.x","volume":"46","author":"JA Charles","year":"2006","unstructured":"Charles JA, Jotkowitz S, Byrd LH. Prevention of migraine with olmesartan in patients with hypertension\/prehypertension. Headache J Head Face Pain. 2006;46(3):503\u20137.","journal-title":"Headache J Head Face Pain"},{"issue":"5","key":"6074_CR23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1517\/14740338.2013.816674","volume":"12","author":"G Derosa","year":"2013","unstructured":"Derosa G, Cicero AFG, Carbone A, Querci F, Fogari E, D\u2019Angelo A, et al. Evaluation of safety and efficacy of a fixed olmesartan\/amlodipine combination therapy compared to single monotherapies. Expert Opin Drug Saf. 2013;12(5):621\u20139.","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"6074_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0304-3959(83)90126-4","volume":"17","author":"DD Price","year":"1983","unstructured":"Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 1983;17(1):45\u201356.","journal-title":"Pain"},{"key":"6074_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/898361","volume":"2014","author":"S Ganjali","year":"2014","unstructured":"Ganjali S, Sahebkar A, Mahdipour E, Jamialahmadi K, Torabi S, Akhlaghi S, et al. Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial. Sci World J. 2014;2014:1.","journal-title":"Sci World J"},{"key":"6074_CR26","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.biopha.2016.05.037","volume":"82","author":"Y Panahi","year":"2016","unstructured":"Panahi Y, Hosseini MS, Khalili N, Naimi E, Simental-Mend\u00eda LE, Majeed M, et al. Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: a post-hoc analysis of a randomized controlled trial. Biomed Pharmacother. 2016;82:578\u201382.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"6074_CR27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.intimp.2014.06.035","volume":"22","author":"MH Seyedzadeh","year":"2014","unstructured":"Seyedzadeh MH, Safari Z, Zare A, Navashenaq JG, Kardar GA, Khorramizadeh MR. Study of curcumin immunomodulatory effects on reactive astrocyte cell function. Int Immunopharmacol. 2014;22(1):230\u20135.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"6074_CR28","first-page":"1","volume":"5","author":"J-J Chen","year":"2015","unstructured":"Chen J-J, Dai L, Zhao L-X, Zhu X, Cao S, Gao Y-J. Intrathecal curcumin attenuates pain hypersensitivity and decreases spinal neuroinflammation in rat model of monoarthritis. Sci Rep. 2015;5(1):1\u201312.","journal-title":"Sci Rep"},{"issue":"1","key":"6074_CR29","first-page":"1891","volume":"7","author":"NA Ismail","year":"2016","unstructured":"Ismail NA, Abd El Dayem SM, Salama E, Ragab S, Abd El Baky AN, Ezzat WM. Impact of curcumin intake on gluco-insulin homeostasis, leptin and adiponectin in obese subjects. Res J Pharm Biol Chem Sci. 2016;7(1):1891\u20137.","journal-title":"Res J Pharm Biol Chem Sci"},{"issue":"1","key":"6074_CR30","first-page":"887","volume":"5","author":"NA Ismail","year":"2014","unstructured":"Ismail NA, Ragab S, El-Baky A, Hamed M, Ibrahim A. Effect of oral curcumin administration on insulin resistance, serum resistin and fetuin-A in obese children: randomized placebo-controlled study. Res J Pharm Biol Chem Sci. 2014;5(1):887\u201396.","journal-title":"Res J Pharm Biol Chem Sci"},{"key":"6074_CR31","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1590\/s0102-865020160110000001","volume":"31","author":"C Li","year":"2016","unstructured":"Li C, Li J, Chen Y, Zhong X, Kang M. Effect of curcumin on visfatin and zinc-\u03b12-glycoprotein in a rat model of non-alcoholic fatty liver disease1. Acta cirurgica brasileira. 2016;31:706\u201313.","journal-title":"Acta cirurgica brasileira"},{"issue":"6","key":"6074_CR32","doi-asserted-by":"publisher","first-page":"874","DOI":"10.2174\/1871530319666190212170140","volume":"19","author":"M Abdolahi","year":"2019","unstructured":"Abdolahi M, Jafarieh A, Sarraf P, Sedighiyan M, Yousefi A, Tafakhori A, et al. The neuromodulatory effects of \u03c9-3 fatty acids and nano-curcumin on the COX-2\/iNOS network in migraines: a clinical trial study from gene expression to clinical symptoms. Endocr Metab Immune Disord Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). 2019;19(6):874\u201384.","journal-title":"Endocr Metab Immune Disord Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders)"},{"issue":"6","key":"6074_CR33","first-page":"430","volume":"17","author":"M Abdolahi","year":"2018","unstructured":"Abdolahi M, Sarraf P, Javanbakht MH, Honarvar NM, Hatami M, Soveyd N, et al. A novel combination of \u03c9-3 fatty acids and nano-curcumin modulates interleukin-6 gene expression and high sensitivity C-reactive protein serum levels in patients with migraine: a randomized clinical trial study. CNS Neurol Disord Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). 2018;17(6):430\u20138.","journal-title":"CNS Neurol Disord Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders)"},{"key":"6074_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-021-05700-x","author":"M Abdolahi","year":"2021","unstructured":"Abdolahi M, Karimi E, Sarraf P, Tafakhori A, Siri G, Sedighiyan M, et al. he omega-3 and Nano-curcumin effects on vascular cell adhesion molecule (VCAM) in episodic migraine patients: a randomized clinical trial. BMC Res Notes. 2021. https:\/\/doi.org\/10.1186\/s13104-021-05700-x.","journal-title":"BMC Res Notes"},{"key":"6074_CR35","doi-asserted-by":"publisher","first-page":"279","DOI":"10.22203\/eCM.v033a21","volume":"33","author":"L Xiao","year":"2017","unstructured":"Xiao L, Ding M, Fernandez A, Zhao P, Jin L, Li X. Curcumin alleviates lumbar radiculopathy by reducing neuroinflammation, oxidative stress and nociceptive factors. Eur Cell Mater. 2017;33:279.","journal-title":"Eur Cell Mater"},{"issue":"4","key":"6074_CR36","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1093\/bja\/aet176","volume":"111","author":"J Lee","year":"2013","unstructured":"Lee J, Shin T, Choi J, Seo K, Kim H, Yoon T, et al. Antinociceptive curcuminoid, KMS4034, effects on inflammatory and neuropathic pain likely via modulating TRPV1 in mice. Br J Anaesth. 2013;111(4):667\u201372.","journal-title":"Br J Anaesth"},{"issue":"3","key":"6074_CR37","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s11064-014-1489-6","volume":"40","author":"AK Singh","year":"2015","unstructured":"Singh AK, Vinayak M. Curcumin attenuates CFA induced thermal hyperalgesia by modulation of antioxidant enzymes and down regulation of TNF-\u03b1, IL-1\u03b2 and IL-6. Neurochem Res. 2015;40(3):463\u201372.","journal-title":"Neurochem Res"},{"issue":"8","key":"6074_CR38","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1089\/jwh.2018.7274","volume":"27","author":"RA Schroeder","year":"2018","unstructured":"Schroeder RA, Brandes J, Buse DC, Calhoun A, Eikermann-Haerter K, Golden K, et al. Sex and gender differences in migraine\u2014evaluating knowledge gaps. J Womens Health. 2018;27(8):965\u201373.","journal-title":"J Womens Health"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-022-06074-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-022-06074-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-022-06074-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T11:07:17Z","timestamp":1653304037000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-022-06074-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6074"],"URL":"https:\/\/doi.org\/10.1186\/s13104-022-06074-4","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,23]]},"assertion":[{"value":"20 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current clinical trial study was approved by the Ethics Committee of Tehran University of Medical Sciences as ID: IR.TUMS.MEDICINE.REC.1399.190 and registered in Iranian Registry of Clinical Trials (IRCT) as ID: IRCT20160626028637N2. The Participants completed a written consent prior of including into the study and being informed about study protocol.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors in this study declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}